Psychedelic Stocks Surge on White House FDA Speedup

Psychedelic biotech stocks like PBM, CMPS, and ATAI soar after a White House order demands faster FDA reviews, signaling real momentum for innovative treatments long stalled by bureaucratic red tape. This America First push cuts through globalist-style overregulation, prioritizing American patients and entrepreneurs over endless government delays. Read more about this...